These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32015157)

  • 1. ARID1A Hypermethylation Disrupts Transcriptional Homeostasis to Promote Squamous Cell Carcinoma Progression.
    Luo Q; Wu X; Chang W; Zhao P; Zhu X; Chen H; Nan Y; Luo A; Zhou X; Su D; Jiao W; Liu Z
    Cancer Res; 2020 Feb; 80(3):406-417. PubMed ID: 32015157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
    Zhang S; Zhou YF; Cao J; Burley SK; Wang HY; Zheng XFS
    Cancer Res; 2021 Nov; 81(22):5652-5665. PubMed ID: 34429326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.
    Luo Q; Wu X; Nan Y; Chang W; Zhao P; Zhang Y; Su D; Liu Z
    Cell Rep; 2020 Jan; 30(1):98-111.e5. PubMed ID: 31914402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress.
    Tomihara H; Carbone F; Perelli L; Huang JK; Soeung M; Rose JL; Robinson FS; Lissanu Deribe Y; Feng N; Takeda M; Inoue A; Poggetto ED; Deem AK; Maitra A; Msaouel P; Tannir NM; Draetta GF; Viale A; Heffernan TP; Bristow CA; Carugo A; Genovese G
    Cancer Res; 2021 Jan; 81(2):332-343. PubMed ID: 33158812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWI/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells.
    Wu S; Fatkhutdinov N; Fukumoto T; Bitler BG; Park PH; Kossenkov AV; Trizzino M; Tang HY; Zhang L; Gardini A; Speicher DW; Zhang R
    Nat Commun; 2018 Oct; 9(1):4116. PubMed ID: 30297712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of ARID1A induces a stemness gene ALDH1A1 expression with histone acetylation in the malignant subtype of cholangiocarcinoma.
    Yoshino J; Akiyama Y; Shimada S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Yamaoka S; Tanabe M; Tanaka S
    Carcinogenesis; 2020 Jul; 41(6):734-742. PubMed ID: 31665232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
    Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H
    Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.
    Nagarajan S; Rao SV; Sutton J; Cheeseman D; Dunn S; Papachristou EK; Prada JG; Couturier DL; Kumar S; Kishore K; Chilamakuri CSR; Glont SE; Archer Goode E; Brodie C; Guppy N; Natrajan R; Bruna A; Caldas C; Russell A; Siersbæk R; Yusa K; Chernukhin I; Carroll JS
    Nat Genet; 2020 Feb; 52(2):187-197. PubMed ID: 31913353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARID1A-mutated ovarian cancers depend on HDAC6 activity.
    Bitler BG; Wu S; Park PH; Hai Y; Aird KM; Wang Y; Zhai Y; Kossenkov AV; Vara-Ailor A; Rauscher FJ; Zou W; Speicher DW; Huntsman DG; Conejo-Garcia JR; Cho KR; Christianson DW; Zhang R
    Nat Cell Biol; 2017 Aug; 19(8):962-973. PubMed ID: 28737768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.
    Yanagi T; Watanabe M; Hata H; Kitamura S; Imafuku K; Yanagi H; Homma A; Wang L; Takahashi H; Shimizu H; Hatakeyama S
    Cancer Res; 2018 Dec; 78(24):6795-6806. PubMed ID: 30389700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SWI/SNF Alterations in Squamous Bladder Cancers.
    Achenbach F; Rose M; Ortiz-Brüchle N; Seillier L; Knüchel R; Weyerer V; Hartmann A; Morsch R; Maurer A; Ecke TH; Garczyk S; Gaisa NT
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33227989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-7641 depletion suppresses proliferation of gastric cancer cells by targeting ARID1A.
    Yang Y; Yin ZX; Wang ZY; Tian SB; Wang HC; Zhang FX; Li LP; Zheng C; Kong S
    Anticancer Drugs; 2020 Apr; 31(4):368-376. PubMed ID: 31913196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming.
    Suryo Rahmanto Y; Shen W; Shi X; Chen X; Yu Y; Yu ZC; Miyamoto T; Lee MH; Singh V; Asaka R; Shimberg G; Vitolo MI; Martin SS; Wirtz D; Drapkin R; Xuan J; Wang TL; Shih IM
    Nat Commun; 2020 Jun; 11(1):2717. PubMed ID: 32483112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.
    Sun X; Wang SC; Wei Y; Luo X; Jia Y; Li L; Gopal P; Zhu M; Nassour I; Chuang JC; Maples T; Celen C; Nguyen LH; Wu L; Fu S; Li W; Hui L; Tian F; Ji Y; Zhang S; Sorouri M; Hwang TH; Letzig L; James L; Wang Z; Yopp AC; Singal AG; Zhu H
    Cancer Cell; 2017 Nov; 32(5):574-589.e6. PubMed ID: 29136504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma.
    Lu WC; Liu CJ; Tu HF; Chung YT; Yang CC; Kao SY; Chang KW; Lin SC
    Oncotarget; 2016 Aug; 7(35):57254-57267. PubMed ID: 27528032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
    Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
    Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.
    Xiao Y; Lin FT; Lin WC
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33408251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STXBP4 regulates APC/C-mediated p63 turnover and drives squamous cell carcinogenesis.
    Rokudai S; Li Y; Otaka Y; Fujieda M; Owens DM; Christiano AM; Nishiyama M; Prives C
    Proc Natl Acad Sci U S A; 2018 May; 115(21):E4806-E4814. PubMed ID: 29735662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response.
    Bakr A; Della Corte G; Veselinov O; Kelekçi S; Chen MM; Lin YY; Sigismondo G; Iacovone M; Cross A; Syed R; Jeong Y; Sollier E; Liu CS; Lutsik P; Krijgsveld J; Weichenhan D; Plass C; Popanda O; Schmezer P
    Nucleic Acids Res; 2024 Jun; 52(10):5698-5719. PubMed ID: 38587186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging roles of ARID1A in tumor suppression.
    Wu RC; Wang TL; Shih IeM
    Cancer Biol Ther; 2014 Jun; 15(6):655-64. PubMed ID: 24618703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.